Diversity in clinical trials is an important issue, as minorities sometimes respond differently to medical products. Race and ethnicity could affect the dose a person needs, or something even more serious. But racial and ethnic minorities are not well represented in clinical trials, and that means health disparities may continue to exist.
The U.S. Food and Drug Administrtation’s Office of Minority Health has released six new public service announcements, a blog and an infographic that can be used to encourage minorities to join clinical trials. Visit the Clinical Trial Diversity Stakeholder Communications Toolkit to learn more: http://bit.ly/29YJ4rS
Email Emily Hamstra (firstname.lastname@example.org) to receive a digest of the day’s BHIC posts via email.